Health & Safety Industry Today

Viral Inactivation Market to Reach USD 10.78 Billion by 2031 on Rising Biologics Manufacturing and Blood Safety Requirements

The viral inactivation market is expanding steadily as demand increases for safe biologics, plasma-derived products, and blood components. Growth is driven by strict regulatory requirements, higher production of monoclonal antibodies and vaccines, and routine use of viral inactivation steps in bioprocessing. North America leads the market, while Asia-Pacific is growing at a faster pace.
Published 08 February 2026

Viral Inactivation Market Analysis 

The viral inactivation market plays a vital role in ensuring the safety of biologics, vaccines, blood products, and plasma-derived therapies. Viral inactivation methods are used to reduce or eliminate viral contaminants during manufacturing and processing. These steps are critical for meeting regulatory standards and protecting patient safety, particularly in large-scale biopharmaceutical production. 

According to Mordor Intelligence, the viral inactivation industry is projected to reach approximately USD 10.78 billion by 2031, growing at a 7.93% CAGR during the forecast period. Increasing production of monoclonal antibodies, recombinant proteins, and plasma-derived therapies is supporting demand for validated viral inactivation processes. In addition, growth in contract manufacturing and stricter quality control requirements are reinforcing market expansion across pharmaceutical and biotechnology companies. 

Viral Inactivation Market Trends & Forecast 

  • Rising use of viral inactivation in monoclonal antibody and vaccine manufacturing 
  • Increased demand for viral safety solutions in plasma-derived and blood products 
  • Wider adoption of solvent/detergent and low pH treatment methods 
  • Growth in outsourced bioprocessing and contract manufacturing services 
  • Strong regulatory focus on viral safety validation in biologics production 

Viral Inactivation Market Segmentation 

By Method 

Solvent-Detergent 

Low-pH Adjustment 

Pasteurization / Heat 

Other Methods 

By Product 

Viral Inactivation Systems & Accessories 

Kits & Reagents 

Validation & Testing Services 

Other Products 

By Application 

Vaccines & Therapeutics 

Blood & Plasma Products 

Cellular & Gene-Therapy Products 

Other Applications 

By End-User 

Biopharma & Biotechnology Companies 

Contract Development & Manufacturing Organizations (CDMOs) 

Contract Research Organizations (CROs) 

Other End-Users 

Key Players 

  • Merck KGaA 
  • Sartorius AG 
  • Texcell SA 
  • Cytiva (Danaher Corporation) 
  • Parker Hannifin Corp 

Explore Our Full Library of Healthcare Research Industry Reports - https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=Industrytoday.co.uk 

United States: Dominating Country Analysis  

The United States holds the largest share of the viral inactivation market due to its strong biopharmaceutical manufacturing base and strict regulatory oversight. The country leads in the production of monoclonal antibodies, vaccines, and plasma-derived therapies, all of which require validated viral inactivation steps. A well-established network of contract development and manufacturing organizations further supports demand. Regulatory agencies emphasize viral safety at every stage of biologics production, driving consistent adoption of inactivation solutions. While Asia-Pacific is expanding rapidly, the United States remains central to process validation, large-scale manufacturing, and compliance standards in the viral inactivation market. 

Trending Reports 

Capillary Electrophoresis Market - https://www.mordorintelligence.com/industry-reports/capillary-electrophoresis-market?utm_source=Industrytoday.co.uk 

Ecotoxicological Studies Market - https://www.mordorintelligence.com/industry-reports/ecotoxicological-studies-market?utm_source=Industrytoday.co.uk 

Gel Permeation Chromatography Market - https://www.mordorintelligence.com/industry-reports/gel-permeation-chromatography-market?utm_source=Industrytoday.co.uk 

Adult Stem Cells Market - https://www.mordorintelligence.com/industry-reports/adult-stem-cells-market?utm_source=Industrytoday.co.uk 

About Mordor Intelligence: 

Mordor Intelligence is a trusted partner for businesses seeking actionable market insights. With 550+ domain experts and specialists across 150+ countries, we deliver comprehensive syndicated and custom research across industries such as aerospace, agriculture, chemicals, consumer goods, energy, healthcare, and many more, helping organizations make informed decisions and achieve strategic goals. 

For any inquiries or to access the full report, please contact: 

media@mordorintelligence.com 

https://www.mordorintelligence.com/

Other Industry News

Ready to start publishing

Sign Up today!